ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock closed at 15.74 per share at the end of the most recent trading day (a -2.54% change compared to the prior day closing price) with a volume of 1.35M shares and market capitalization of 2.55B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 580 people. ACADIA Pharmaceuticals Inc. CEO is Stephen R. Davis.

The one-year performance of ACADIA Pharmaceuticals Inc. stock is -11.89%, while year-to-date (YTD) performance is -32.56%. ACAD stock has a five-year performance of -49.57%. Its 52-week range is between 12.24 and 28.055, which gives ACAD stock a 52-week price range ratio of 22.13%

ACADIA Pharmaceuticals Inc. currently has a PE ratio of -11.50, a price-to-book (PB) ratio of 5.55, a price-to-sale (PS) ratio of 6.43, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -32.41%, a ROC of -37.11% and a ROE of -43.62%. The company’s profit margin is -46.65%, its EBITDA margin is -43.30%, and its revenue ttm is $377.84 Million , which makes it $2.34 revenue per share.

Of the last four earnings reports from ACADIA Pharmaceuticals Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.25 for the next earnings report. ACADIA Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ACADIA Pharmaceuticals Inc. is Moderate Buy (2.29), with a target price of $24.12, which is +53.24% compared to the current price. The earnings rating for ACADIA Pharmaceuticals Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ACADIA Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ACADIA Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.16, ATR14 : 0.99, CCI20 : 115.74, Chaikin Money Flow : 0.03, MACD : 0.14, Money Flow Index : 65.92, ROC : 13.49, RSI : 45.60, STOCH (14,3) : 74.13, STOCH RSI : 0.76, UO : 62.16, Williams %R : -25.87), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ACADIA Pharmaceuticals Inc. in the last 12-months were: Austin D. Kim (Option Excercise at a value of $0), Austin D. Kim (Sold 3 606 shares of value $79 939 ), Brendan P. Teehan (Option Excercise at a value of $0), Brendan P. Teehan (Sold 1 562 shares of value $33 671 ), Elizabeth Garofalo (Option Excercise at a value of $0), James K. Kihara (Option Excercise at a value of $0), James K. Kihara (Sold 1 384 shares of value $36 270 ), Mark Schneyer (Option Excercise at a value of $0), Mark Schneyer (Sold 553 shares of value $13 161 ), Srdjan Stankovic (Option Excercise at a value of $0), Srdjan Stankovic (Sold 10 444 shares of value $209 042 ), Stephen R. Davis (Option Excercise at a value of $0), Stephen R. Davis (Sold 16 092 shares of value $330 463 )